June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Influence of endothelin-1 in aqueous humor on IOP and filtration surgery outcome
Author Affiliations & Notes
  • Lars Choritz
    Ophthalmology, University Medical Center, Mainz, Germany
    Ophthalmology, University Clinic, Otto von Guericke University, Magdeburg, Germany
  • Benjamin Mahmoodi
    Ophthalmology, University Medical Center, Mainz, Germany
  • Maren Machert
    Ophthalmology, University Medical Center, Mainz, Germany
  • Norbert Pfeiffer
    Ophthalmology, University Medical Center, Mainz, Germany
  • Hagen Thieme
    Ophthalmology, University Clinic, Otto von Guericke University, Magdeburg, Germany
  • Footnotes
    Commercial Relationships Lars Choritz, None; Benjamin Mahmoodi, None; Maren Machert, None; Norbert Pfeiffer, Sensimed AG (F), Sensimed AG (R), MSD (F), MSD (R), Alcon (F), Allergan (F), Novartis (F), Novartis (R), Bayer (F), Heidelberg Engineering (F), Bausch&Lomb (F), Boehringer-Ingelheim (F), Carl Zeiss Meditech (F), Chibret (F), Nidek (F), Pfizer (F), Santen (F), Santen (R), Topcon (F), Ivantis Inc (F), Ivantis Inc (R); Hagen Thieme, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4483. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lars Choritz, Benjamin Mahmoodi, Maren Machert, Norbert Pfeiffer, Hagen Thieme; Influence of endothelin-1 in aqueous humor on IOP and filtration surgery outcome. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4483.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: In a previously published study, we found a significant correlation between endothelin-1 in the aqueous humor of glaucoma patients obtained during cataract surgery or trabeculectomy and immediately pre-operative intraocular pressure. The aim of this chart-review study was to assess, whether the previously recorded ET-1 concentrations had any influence on IOP development or surgical outcome during up to five years of follow-up.

Methods: Clinical records of the patients enrolled in the original study were reviewed, post surgical IOP development, number of 5-FU treatments, bleb revisions, further glaucoma surgeries, glaucoma medications and complications were compared between patients with high (above median) and low (below median) ET-1 concentrations in aqueous humor.

Results: Of the 56 glaucoma patients originally enrolled, 51 came into our clinic for further consultations. Median follow-up time was 24 months (range 1 to 59 months). There were no significant differences in IOP at any time point during follow-up. In the subpopulation of patients who had undergone trabeculectomy (n=36), both groups needed the same number of 5-FU injections (5.5±3.7 high vs. 5.1±3.1 low, p=0.74), needlings (0.2±0.7 vs. 0.2±0.7, p=0.82) and suture lyses (0.4±0.8 vs. 0.3±0.7, p=0.65 ) during the post-operative phase. Complication rates and number of revision procedures were equally low in both groups, although all 4 recorded bleb revisions were necessary in the high ET-1 group . At the end of follow-up, the number of glaucoma medications was not significantly different (0.3±0.8 vs. 0.2±0.5, p=0.88).

Conclusions: ET-1 concentrations in aqueous humor do not appear to have any influence on long term outcome or IOP development after filtration surgery. While several animal models as well as our previous clinical study suggest a role for ET-1 in IOP control by inducing contraction of trabecular meshwork (TM), this influence on IOP development is likely reduced once the TM has been shunted. Its predictive value for long term outcome of filtering surgery therefore is limited.

Keywords: 427 aqueous • 464 clinical (human) or epidemiologic studies: risk factor assessment • 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×